AzathioprineRemission InductionRemission, Spontaneous6-MercaptopurineCytarabineAsparaginaseDaunorubicinPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressive AgentsThioguanineLeukemia, Myeloid, AcutePrednisoneMethotrexateVincristinePrednisoloneTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsRecurrenceIdarubicinCyclophosphamideLeukemia, MyeloidLeukemia, LymphoidDrug Therapy, CombinationAcute DiseasePrognosisDisease-Free SurvivalNeoplasm, ResidualBone MarrowLeukemia, Promyelocytic, AcuteTime FactorsDrug Administration ScheduleLeukemiaFollow-Up StudiesEnzyme InductionCrohn DiseaseEtoposideCombined Modality TherapyDoxorubicinColitis, UlcerativeBone Marrow TransplantationSurvival AnalysisLeukocyte CountTransplantation, HomologousBlast CrisisMycophenolic AcidCyclosporineClinical Trials as TopicAntineoplastic AgentsRetrospective StudiesInflammatory Bowel DiseasesMesalamineMethyltransferasesPlatelet CountAntibodies, MonoclonalSurvival RateAdrenal Cortex HormonesHepatitis, AutoimmuneKidney TransplantationProspective StudiesHematopoietic Stem Cell TransplantationGastrointestinal AgentsAnti-Inflammatory AgentsMethylprednisoloneDisseminated Intravascular CoagulationAminosalicylic AcidsLeukopeniaDexamethasoneInjections, SpinalNephrotic SyndromeImmunosuppressionSulfasalazineGlucocorticoidsAntirheumatic AgentsGraft RejectionPulse Therapy, DrugArthritis, RheumatoidTransplantation, AutologousLupus NephritisSeverity of Illness IndexCyclosporinsAge FactorsAntibodies, Monoclonal, Murine-DerivedAntimetabolitesDose-Response Relationship, DrugWegener GranulomatosisVasculitisGraft SurvivalMicroscopic PolyangiitisLymphoma, Non-HodgkinSteroidsAntibodies, Antineutrophil CytoplasmicNiridazoleTacrolimusAntilymphocyte SerumRNA, MessengerMaintenance ChemotherapyProteinuriaAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisCells, CulturedDrug Resistance